Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Aphton Ends Sanofi Deal, Seeks New Insegia Partner

Nov. 11, 2005

By Jennifer Boggs

PTC Raises $26M Privately; Lead Drug To Start Phase II

Nov. 11, 2005

By Jennifer Boggs

Aphton Ends Sanofi Deal, Seeks New Insegia Partner

Nov. 11, 2005

By Jennifer Boggs

PTC Raises $26M Privately; Lead Drug To Start Phase II

Nov. 11, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...